Valuation: Genmab A/S

Market Cap 117B 17.84B 15.65B 14.62B 13.44B 25.15B 1,711B 25.57B 173B 67.71B 845B 67.01B 65.56B 2,923B P/E 2026 *
24.9x
P/E 2027 * 17.3x
Enterprise Value 137B 20.8B 18.25B 17.04B 15.66B 29.32B 1,994B 29.81B 201B 78.92B 985B 78.11B 76.42B 3,407B EV / Sales 2026 *
4.83x
EV / Sales 2027 * 3.89x
Free-Float
95.41%
Yield 2026 *
-
Yield 2027 * -
1 week+3.30%
Current month+6.30%
1 month+12.10%
3 months+11.78%
6 months-11.54%
Current year-5.87%
1 week 1,839
Extreme 1839
1,928
1 month 1,704
Extreme 1704
1,933
Current year 1,512
Extreme 1512
2,257
1 year 1,337
Extreme 1337
2,257
3 years 1,157
Extreme 1157
2,814
5 years 1,157
Extreme 1157
3,327
10 years 786.2
Extreme 786.2
3,327
Manager TitleAgeSince
Chief Executive Officer 65 2010-05-31
Director of Finance/CFO 48 2020-02-29
Chief Tech/Sci/R&D Officer - 2024-08-15
Director TitleAgeSince
Director/Board Member 75 2003-10-31
Director/Board Member 58 2014-12-31
Director/Board Member 75 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Chairman

378 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.30%+28.01%-29.07% 17.83B
-2.25%+2.44%+53.17%+64.57% 56.19B
-1.32%-0.97%+38.41%+77.52% 54.83B
+1.49%+0.31%-19.82%-11.95% 23.04B
-0.57%-2.70%+0.17%+410.44% 22.7B
-0.21%+0.84%+22.48%-7.92% 20.23B
-0.97%+0.89%+37.28%+539.62% 15.65B
-6.69%-5.11%+166.00%+304.89% 15.24B
+1.25%+1.76%+23.93%+188.32% 14.03B
-2.26%+0.58%+80.56%+169.51% 12.71B
Average -1.15%-0.18%+43.02%+170.59% 25.24B
Weighted average by Cap. -1.23%+0.31%+39.88%+135.20%

Financials

2026 *2027 *
Net sales 28.25B 4.3B 3.77B 3.53B 3.24B 6.07B 413B 6.17B 41.63B 16.33B 204B 16.16B 15.81B 705B 33.18B 5.05B 4.43B 4.14B 3.81B 7.12B 485B 7.24B 48.9B 19.18B 239B 18.98B 18.57B 828B
Net income 4.82B 733M 643M 601M 552M 1.03B 70.33B 1.05B 7.1B 2.78B 34.75B 2.75B 2.7B 120B 7.05B 1.07B 943M 880M 809M 1.51B 103B 1.54B 10.4B 4.08B 50.91B 4.04B 3.95B 176B
Net Debt 19.4B 2.96B 2.59B 2.42B 2.23B 4.17B 283B 4.24B 28.59B 11.21B 140B 11.1B 10.86B 484B 11.82B 1.8B 1.58B 1.48B 1.36B 2.54B 173B 2.58B 17.42B 6.83B 85.3B 6.76B 6.61B 295B
Logo Genmab A/S
Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).
Employees
3,088
Date Price Change Volume
26-07-28 DKK 1,908.00 0.00% 110,569
26-07-27 DKK 1,908.00 +1.57% 114,942
26-07-24 DKK 1,878.50 -1.34% 78,748
26-07-23 DKK 1,904.00 -0.37% 85,139
26-07-22 DKK 1,911.00 +3.16% 132,427
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
1,908.00DKK
Average target price
2,392.08DKK
Spread / Average Target
+25.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GMAB Stock